FDA didn't disclose safety panel's ties to Bayer, WSJ says

When an FDA advisory panel voted to support Bayer's birth control pills after new data emerged on their potential to cause blood clots, the agency didn't disclose that three of the committee members have served as consultants, speakers, or researchers for the German company, The Wall Street Journal reports. Report

Suggested Articles

Merck's Keytruda has new long-term survival results that the drugmaker hopes will help bolster its position in first-line NSCLC.

Last year at ESMO, AZ and Merck showed Lynparza topped its rivals at fending off prostate cancer. Now, Lynparza has helped patients live longer, too.

Merck and Eisai are trying to take their Keytruda-Lenvima combo into additional cancers, and new data provide a glimpse of where it might go next.